Article summary
The FDA acceptance of Compass Pathway’s Investigational New Drug Application for their COMP360 compound as a possible therapy for PTSD introduces a new area of possible therapies using psilocybin. The post Legislation, Industry, and the Future of Psilocybin for PTSD first appeared on Lucid News. The post Legislation, Industry, and the Future of Psilocybin for PTSD appeared first on Lucid News.
Continue to the original publication for the complete article.